Multicomponent Model Cellular System for Studying Molecular Mechanisms of Cytotoxicity of Antileukemic Agents
Despite recent advances in chemotherapy, over 20% of leukemia patients suffer from a relapse or refractory disease, largely due to leukemic stem cell survival in specialized bone marrow niches. Malignant cell interactions with stromal elements activate compensatory pathways that inhibit apoptosis and differentiation, enhancing cell survival and drug resistance. Overcoming this resistance requires novel therapeutic targets and adequate models for testing their inhibitors. An experimental co-culture model was developed using suspension blood cell lines and HS-5 stromal cells with ectopic expression of the enhanced green fluorescent protein (eGFP). The model allows efficient separation and analysis of suspension and adherent fractions using flow cytometry. Co-culture with the stroma was shown to promote leukemic cell survival and adhesion. Interestingly, treatment with the cytostatic drug cytarabine enhanced tumor cell adhesion, while hypoxia reduced adhesion. Additionally, contact with HS-5 fibroblasts significantly upregulated expression of key chemokines, their receptors, and cell adhesion molecules in leukemic cells. The model was thus found to provide an attractive tool for studying the mechanisms of stroma-dependent resistance and developing novel approaches to overcoming chemotherapy resistance in leukemia.
Authors
- Timofey D. Lebedev (ORCID: https://orcid.org/0000-0002-5966-0914)
- Pavel Spirin (ORCID: https://orcid.org/0000-0002-0610-5079)
- Valeria Vedernikova (ORCID: https://orcid.org/0009-0002-4451-2393)
- Vladimir Prassolov (ORCID: https://orcid.org/0000-0002-2429-6649)
- Karina A. Ivanenko (ORCID: https://orcid.org/0000-0001-8496-3338)
- K. A. Glumakova
Institutions
- Engelhardt Institute of Molecular Biology (RU)
- Russian Academy of Sciences (RU)
Publication Details
- Journal
- Molecular Biology
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1134/s0026893326606622
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00